Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,848 | 252 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $731.41 | 36 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $628.40 | 42 | $0 (2020) |
| UCB, Inc. | $553.99 | 31 | $0 (2024) |
| PFIZER INC. | $469.76 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $412.30 | 25 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $243.80 | 11 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $241.70 | 12 | $0 (2024) |
| MDD US Operations, LLC | $215.55 | 12 | $0 (2024) |
| CSL Behring | $211.03 | 10 | $0 (2024) |
| LivaNova USA, Inc. | $155.44 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,537 | 74 | UCB, Inc. ($402.48) |
| 2023 | $593.50 | 30 | Eisai Inc. ($144.43) |
| 2022 | $673.20 | 36 | EISAI INC. ($347.54) |
| 2021 | $471.14 | 26 | Eisai Inc. ($207.14) |
| 2020 | $522.03 | 34 | Supernus Pharmaceuticals, Inc. ($278.33) |
| 2019 | $464.45 | 28 | Supernus Pharmaceuticals, Inc. ($236.78) |
| 2018 | $528.62 | 20 | LivaNova USA, Inc. ($114.97) |
| 2017 | $58.46 | 4 | LivaNova USA, Inc. ($20.31) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Neuropsychiatry | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: PAIN | ||||||
| 12/17/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Neurology | ||||||
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: PAIN | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.93 | General |
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Neurology | ||||||
| 11/15/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Neurology | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $129.50 | General |
| Category: PAIN | ||||||
| 11/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Neurology | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: PAIN | ||||||
| 10/21/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $92.87 | General |
| Category: Epilepsy | ||||||
| 10/21/2024 | AQUESTIVE THERAPEUTICS, INC. | LIBERVANT (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | Azurity Pharmaceuticals, Inc. | ZONISADE (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Neuropsychiatry | ||||||
| 10/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $38.67 | General |
| Category: Neurology | ||||||
| 10/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Neurology | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: PAIN | ||||||
| 09/16/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Pain Management | ||||||
| 09/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neurology | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: PAIN | ||||||
| 08/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Neurology | ||||||
| 08/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 575 | 944 | $225,513 | $79,882 |
| 2022 | 5 | 669 | 1,144 | $269,593 | $94,776 |
| 2021 | 5 | 767 | 1,277 | $303,379 | $108,476 |
| 2020 | 8 | 606 | 998 | $231,430 | $84,028 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 216 | 232 | $97,904 | $29,666 | 30.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 129 | 258 | $55,986 | $22,819 | 40.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 168 | 375 | $57,000 | $21,935 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $5,567 | $2,391 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 28 | $6,048 | $2,344 | 38.8% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 21 | 32 | $3,008 | $728.32 | 24.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 271 | 289 | $121,958 | $42,452 | 34.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 230 | 623 | $94,696 | $33,116 | 35.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 114 | 167 | $36,239 | $12,710 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 51 | $11,016 | $4,174 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $5,684 | $2,324 | 40.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 318 | 336 | $141,792 | $50,511 | 35.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 266 | 698 | $106,096 | $37,868 | 35.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 115 | 153 | $33,201 | $11,809 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 51 | $11,016 | $4,024 | 36.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $6,090 | $2,439 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 24 | $5,184 | $1,824 | 35.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 230 | 247 | $104,234 | $38,002 | 36.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 194 | 501 | $76,152 | $27,824 | 36.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 62 | 90 | $19,530 | $7,218 | 37.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 38 | $8,208 | $2,662 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 16 | 27 | $5,832 | $1,584 | 27.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 12 | 12 | $4,872 | $1,551 | 31.8% |
| 99449 | Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review | Facility | 2020 | 26 | 28 | $4,396 | $1,546 | 35.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $5,278 | $1,489 | 28.2% |
About Dr. Kofi Quist, MD
Dr. Kofi Quist, MD is a Geriatric Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1932428836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kofi Quist, MD has received a total of $4,848 in payments from pharmaceutical and medical device companies, with $1,537 received in 2024. These payments were reported across 252 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,848).
As a Medicare-enrolled provider, Quist has provided services to 2,617 Medicare beneficiaries, totaling 4,363 services with total Medicare billing of $367,162. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location Indianapolis, IN
- Active Since 05/18/2010
- Last Updated 07/30/2025
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1932428836
Products in Payments
- Fycompa (Drug) $702.87
- OXTELLAR XR (Drug) $576.17
- NURTEC ODT (Drug) $422.15
- Briviact (Drug) $300.35
- Nayzilam (Drug) $253.64
- KESIMPTA (Drug) $246.43
- FYCOMPA (Drug) $226.18
- Hizentra (Biological) $211.03
- INGREZZA (Drug) $184.45
- VNS Therapy (Device) $155.44
- Apokyn (Drug) $114.56
- SOLIRIS (Drug) $112.86
- RNS Neurostimulator Kit (Device) $92.87
- MAYZENT (Drug) $85.52
- GILENYA (Drug) $80.35
- WAKIX (Drug) $78.29
- NUPLAZID (Drug) $76.46
- VALTOCO (Drug) $72.02
- LYRICA (Drug) $60.22
- Ongentys (Drug) $59.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Indianapolis
Malaz Boustani, Md, MD
Geriatric Medicine — Payments: $166,060
Dr. Robert Lebow, M.d.,, M.D.,
Geriatric Medicine — Payments: $5,080
Kevin Mcnulty, Do, DO
Geriatric Medicine — Payments: $873.13
Dr. Linda Morse, Do, DO
Geriatric Medicine — Payments: $689.55
Leo Solito
Geriatric Medicine — Payments: $616.04
Joan Chang, Do, DO
Geriatric Medicine — Payments: $405.61